Robust Experience in Healthcare
Our deep expertise and focus on oncology and specialty therapies includes, but is not limited to, expertise in growing areas such as rare disease, biosimilars, companion diagnostics, and cell and gene therapy
View our case studies below to see how we’ve successfully partnered with pharma by co-creating the support systems needed to be successful in complex Oncology launches.
On average, a Rare Disease patient may see doctors for five years before reaching a diagnosis. The rare disease community deserves the same resilience from healthcare providers that they bring to each new day. Amplity Health is committed to partnering with pharma active in the Rare Disease space from engagement, education, and advocacy to testing, diagnosis, and treatment:
- Patient engagement and advocacy
- Key Opinion Leader (KOL) and medical community network building
- Understanding Patient and Physician challenges
- Disease education
- Scientific exchange of disease information with Healthcare Providers (HCPs)
- HCP community building for referral networks
- Genetic/Diagnostic testing capability and execution
- Patient identification and support services triaging
- Cross-functional partnership for testing pull-through
Read our case studies below to see how we’ve partnered with pharma to co-create solutions that ensure Rare Disease patients gain access to and benefit from the best medicine for the right reasons.